{"id":"https://openalex.org/W2762091508","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e13100","title":"Somatic versus germline BRCA mutations screening in ovarian cancer.","display_name":"Somatic versus germline BRCA mutations screening in ovarian cancer.","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W2762091508","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e13100","mag":"2762091508"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.e13100","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e13100","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.e13100","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082018913","display_name":"Hugo Nunes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Hugo SM Nunes","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Patricia Machado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Patricia Machado","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027040222","display_name":"Sofia Fragoso","orcid":"https://orcid.org/0000-0001-8102-6883","observed_orcids":["https://orcid.org/0000-0001-8102-6883"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Sofia Fragoso","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058789687","display_name":"Samuel D\u00e9cio Azevedo dos Santos","orcid":"https://orcid.org/0000-0002-6633-0657","observed_orcids":["https://orcid.org/0000-0002-6633-0657"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Sidonia Santos","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100779237","display_name":"FERNANDA ATILA BARBOSA NUNES DA SILVA","orcid":"https://orcid.org/0000-0002-7652-6493","observed_orcids":["https://orcid.org/0000-0002-7652-6493"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Fernanda Silva","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040765699","display_name":"Ana F\u00e9lix","orcid":"https://orcid.org/0000-0002-2653-2262","observed_orcids":["https://orcid.org/0000-0002-2653-2262"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Felix","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086737774","display_name":"Ana S\u00edlvia Lu\u00eds","orcid":"https://orcid.org/0000-0001-5067-903X","observed_orcids":["https://orcid.org/0000-0001-5067-903X"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Lu\u00eds","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112385869","display_name":"Ana Opini\u00e3o","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Opiniao","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109389618","display_name":"Ana Isabel Clara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Clara","raw_affiliation_strings":["Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102445680","display_name":"Sandra Bento","orcid":"https://orcid.org/0000-0002-2838-2288","observed_orcids":["https://orcid.org/0000-0002-2838-2288"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra Bento","raw_affiliation_strings":["Hosp. Santarem, Santar\u00e9m, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hosp. Santarem, Santar\u00e9m, Portugal;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103783147","display_name":"Ana Miranda","orcid":"https://orcid.org/0000-0002-8300-6293","observed_orcids":["https://orcid.org/0000-0002-8300-6293"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Miranda","raw_affiliation_strings":["Service of Epidemiology, Portuguese Institute of Oncology, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service of Epidemiology, Portuguese Institute of Oncology, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112051824","display_name":"Ana Francisca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Francisca","raw_affiliation_strings":["Service of Gynecology, Portuguese Institute of Oncology, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service of Gynecology, Portuguese Institute of Oncology, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089139257","display_name":"F\u00e1tima Vaz","orcid":"https://orcid.org/0000-0002-3334-215X","observed_orcids":["https://orcid.org/0000-0002-3334-215X"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Fatima H. Vaz","raw_affiliation_strings":["Portuguese Institute of Oncology Libon, Lisbon, Portugal;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Portuguese Institute of Oncology Libon, Lisbon, Portugal;","institution_ids":["https://openalex.org/I4210103180"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"e13100","last_page":"e13100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9200000166893005},{"id":"https://openalex.org/keywords/somatic-brca-mutations","display_name":"somatic BRCA mutations","score":0.9049999713897705},{"id":"https://openalex.org/keywords/germline-brca-mutation","display_name":"germline BRCA mutation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.9559999704360962},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/high-grade-serous-ovarian-carcinoma","display_name":"high-grade serous ovarian cancer","score":0.6690000295639038},{"id":"https://openalex.org/keywords/variant-allele-frequency","display_name":"variant allele frequency","score":0.7120000123977661},{"id":"https://openalex.org/keywords/alu-insertion","display_name":"Alu insertion","score":0.5509999990463257},{"id":"https://openalex.org/keywords/large-rearrangements","display_name":"large rearrangements","score":0.7480000257492065},{"id":"https://openalex.org/keywords/multiplex-ligation-dependent-probe-amplification","display_name":"multiplex ligation-dependent probe amplification","score":0.7580000162124634},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.6779999732971191},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.6370000243186951},{"id":"https://openalex.org/keywords/platinum-sensitivity","display_name":"platinum sensitivity","score":0.7879999876022339},{"id":"https://openalex.org/keywords/brca-mutation-carriers","display_name":"BRCA mutation carriers","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.699866533279419},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6818248629570007},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.6501399874687195},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6456485390663147},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.6268424987792969},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.5813541412353516},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5273186564445496},{"id":"https://openalex.org/C2780194787","wikidata":"https://www.wikidata.org/wiki/Q4836333","display_name":"BRCA mutation","level":4,"score":0.5198993682861328},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46873173117637634},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.44803616404533386},{"id":"https://openalex.org/C2909462720","wikidata":"https://www.wikidata.org/wiki/Q421651","display_name":"BRCA2 Protein","level":5,"score":0.41171661019325256},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.4104384779930115},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39082908630371094},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3848460018634796},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3628104627132416},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27607831358909607},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.16743671894073486},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.e13100","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e13100","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.e13100","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3030744594","https://openalex.org/W2974020181","https://openalex.org/W2389186765","https://openalex.org/W2486789393","https://openalex.org/W2267313561","https://openalex.org/W2939601237","https://openalex.org/W2237354940","https://openalex.org/W2890226973","https://openalex.org/W2890060779","https://openalex.org/W2604388517"],"abstract_inverted_index":{"e13100":[0],"Background:":[1],"ovarian":[2],"cancer":[3],"(OC)":[4],"with":[5,274,325],"germinal":[6,315],"or":[7],"somatic":[8,24,35,219,238,278,310,327],"BRCA":[9,23,34,61,91,299],"mutations":[10,93,239,317],"responds":[11],"better":[12],"to":[13,16,29,248,304],"platinum":[14],"and":[15,36,60,73,106,109,128,182,207,266,318,341],"PARP-inhibitors.":[17],"There":[18],"is":[19],"great":[20],"enthusiasm":[21],"about":[22],"screening.":[25],"Our":[26],"aim":[27],"was":[28,46,118,152,210,221,261],"analyse":[30],"the":[31,53,83,139,264,281,305],"correlation":[32,209,331],"between":[33,58],"germline":[37],"mutational":[38],"profile.":[39],"Methods:":[40],"a":[41,190,224],"cohort":[42],"of":[43,123,125,138,187,193,228,297,322,334],"23":[44,140],"pts":[45,51,79,141,167,200,255,324],"obtained":[47],"by":[48,113,133,291],"cross-linking":[49],"OC":[50,309],"from":[52,120],"South":[54],"Portuguese":[55,85],"Cancer":[56],"Registry,":[57],"2009-2014":[59],"mutation":[62,87,220],"carriers":[63,162,181,245],"identified":[64],"in":[65,99,243,293],"our":[66,294],"Clinic.":[67],"Medical":[68],"records":[69],"were":[70,80,97,158,179,184,204,233,240],"reviewed:":[71],"demographic":[72],"clinico-pathologic":[74],"data":[75,302],"obtained.":[76],"Germinal":[77],"screening:":[78,116],"pre-screened":[81],"for":[82,90,110,130,212,280],"BRCA2":[84,157,185,218],"founder":[86],"(PFM),":[88],"analysed":[89,129,206],"point":[92,214,316],"(different":[94],"screening":[95,279,311],"methodologies":[96],"used":[98],"diagnostic":[100],"timeline:":[101],"initially":[102],"CSGE,":[103],"then":[104],"CSCE":[105],"finally":[107],"NGS)":[108],"large":[111,191,268],"rearrangements":[112,269,288],"MLPA.":[114],"Somatic":[115,197],"DNA":[117],"extracted":[119],"5":[121],"sections":[122],"10\u00b5m":[124],"FFPE":[126],"tissue":[127],"BRCA1/2":[131],"genes":[132],"NGS.":[134,275],"Results:":[135],"clinico-pathological":[136],"features":[137],"revealed":[142],"mainly":[143],"high-grade":[144],"serous":[145],"histology":[146],"(96%).":[147],"Mean":[148],"age":[149],"at":[150,169],"diagnosis":[151],"54":[153],"years":[154],"old":[155],"(33-76);":[156],"older":[159],"than":[160],"BRCA1":[161,180],"(62":[163],"vs":[164],"51).":[165],"Most":[166],"presented":[168],"advanced":[170],"stage":[171,176],"(70%":[172],"stages":[173],"III-IV;":[174],"30%":[175],"I-II).":[177],"Seventeen":[178],"6":[183],"(5":[186,201],"those":[188],"PFM,":[189],"insertion":[192],"an":[194,319],"Alu":[195],"element).":[196],"correlation:":[198],"8":[199],"BRCA1,":[202],"3PFM)":[203],"already":[205],"100%":[208],"observed":[211,242],"all":[213,298,314],"mutations.":[215,328],"One":[216],"additional":[217,323],"detected":[222,273],"(with":[223],"variant":[225],"allele":[226],"frequency":[227],"53%":[229],"whereas":[230],"2":[231],"others":[232],"<":[234],"7%);":[235],"interestingly":[236],"exclusive":[237,326],"only":[241],"PFM":[244,265,282],"(known":[246],"not":[247,271],"be":[249,272,284],"NGS":[250,308],"detectable).":[251],"The":[252],"remaining":[253],"15":[254],"are":[256,289],"under":[257],"analysis.":[258],"Conclusions:":[259],"it":[260],"expected":[262],"that":[263,307,336],"other":[267,287],"would":[270],"A":[276],"specific":[277],"may":[283,337],"possible":[285],"but":[286],"found":[290],"MLPA":[292],"population":[295],"(10%":[296],"mutations).":[300],"Preliminary":[301],"adds":[303],"evidence":[306],"will":[312],"identify":[313],"indeterminate":[320],"number":[321],"An":[329],"ideal":[330],"needs":[332],"integration":[333],"differenttechniques":[335],"increase":[338],"complexity,":[339],"time":[340],"cost.":[342]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-10-20T00:00:00"}